The C1orf112 antibody is a research tool designed to target the protein encoded by the *C1orf112* gene (Chromosome 1 Open Reading Frame 112), a poorly characterized gene located on human chromosome 1. The gene's function remains largely unknown, though bioinformatic analyses suggest it may play roles in cellular processes such as DNA repair or cell cycle regulation. The encoded protein is predicted to contain coiled-coil domains, which are often involved in protein-protein interactions. C1orf112 antibodies are primarily used in experimental settings, including Western blotting, immunofluorescence, and immunohistochemistry, to detect protein expression levels, subcellular localization, and potential interaction partners.
Interest in C1orf112 has grown due to its reported associations with diseases such as cancer and neurodegenerative disorders, though mechanistic insights are limited. Some studies link its expression to tumor progression or chemoresistance, while others propose involvement in neuronal development. Commercial availability of C1orf112 antibodies is limited, and validation data (e.g., knockout controls) are critical to confirm specificity, as non-specific binding has been noted in some cases. Researchers often employ these antibodies to explore its tissue-specific expression patterns or to verify CRISPR/Cas9-mediated gene editing. Despite its enigmatic nature, C1orf112 represents a potential biomarker or therapeutic target, driving demand for reliable antibodies to advance functional studies. Further research is needed to clarify its biological significance and disease relevance.